Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Fourth Controlled Human Infection Model (CHIM) meeting – CHIMs in endemic countries, May 22–23, 2023
Kapulu M. et al, (2024), Biologicals, 101747 - 101747
Age-dependent acquisition of IgG antibodies to Shigella serotypes—a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccination
Kapulu MC. et al, (2024), Frontiers in Immunology, 15
Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues, May 24, 2023
Cavaleri M. et al, (2024), Biologicals
The Dantu blood group prevents parasite growth in vivo: Evidence from a controlled human malaria infection study.
Kariuki SN. et al, (2023), eLife, 12
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.
Odera DO. et al, (2023), Science translational medicine, 15
Human infection challenge in the pandemic era and beyond, HIC-Vac annual meeting report, 2022.
Barnes MVC. et al, (2023), Immunotherapy advances, 3
Sporozoite immunization: innovative translational science to support the fight against malaria.
Richie TL. et al, (2023), Expert review of vaccines, 22, 964 - 1007
Controlled human malaria infection (CHMI) outcomes in Kenyan adults is associated with prior history of malaria exposure and anti-schizont antibody response
Kapulu MC. et al, (2022), BMC Infectious Diseases, 22
Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria.
Musasia FK. et al, (2022), Nature communications, 13
Ethical considerations around volunteer payments in a malaria human infection study in Kenya: an embedded empirical ethics study.
Chi PC. et al, (2022), BMC medical ethics, 23
Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop.
Williams E. et al, (2022), Vaccine
Breadth of Antibodies to Plasmodium falciparum Variant Surface Antigens Is Associated With Immunity in a Controlled Human Malaria Infection Study.
Kimingi HW. et al, (2022), Frontiers in immunology, 13
Complement-mediated serum bactericidal activity of antibodies elicited by the Shigella sonnei GMMA vaccine in adults from a shigellosis-endemic country: Exploratory analysis of a Phase 2a randomized study.
Kapulu MC. et al, (2022), Frontiers in immunology, 13
Undertaking Community Engagement for a Controlled Human Malaria Infection Study in Kenya: Approaches and Lessons Learnt.
Mumba N. et al, (2022), Frontiers in public health, 10
Engagement of ethics and regulatory authorities on human infection studies: Proceedings of an engagement workshop in Zambia
Kunda-Ng'andu EM. et al, (2021), Wellcome Open Research, 6, 31 - 31
Safety and PCR monitoring in 161 semi-immune Kenyan adults following controlled human malaria infection
Kapulu MC. et al, (2021), JCI Insight, 6
Equity for excellence in academic institutions: a manifesto for change
Wedekind L. et al, (2021), Wellcome Open Research, 6, 142 - 142